Irene Perlich - 16 Jan 2024 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC

Signature
/s/ Valerie Pierce, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Jan 2024
Net transactions value
-$1,374
Form type
4
Filing time
18 Jan 2024, 18:02:56 UTC
Previous filing
08 Nov 2023
Next filing
08 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Tax liability $1,374 -1,025 -10% $1.34 8,975 16 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the issuer to satisfy the tax obligation realized in connection with the vesting of restricted stock units previously reported in Table 1.